The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes
    • eBooks

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Pathology Captures
Subscribe
Subscribe

False

The Pathologist / Issues / 2026 / September / Why We Need Biomarkers in Psychiatry
Neurology Biochemistry and molecular biology Guidelines and Recommendations Liquid biopsy

Why We Need Biomarkers in Psychiatry

Consensus statement outlines how standardized, validated biological tests could move psychiatric diagnosis and treatment beyond symptom-based classification

09/30/2026 News 2 min read
  • Full Article
  • Summary
  • Takeaways
  • Report
  • Scorecard
  • Quiz
  • Poll
  • Topic Commentary

Share

4 Topic Commentaries

Why We Need Biomarkers in Psychiatry

Why We Need Biomarkers in Psychiatry

  • Leanne Williams
    Leanne Williams, PhD

    Psychiatry and Behavioral Sciences

    •

    Stanford School of Medicine

    The brain is an essential starting place with these conditions.

    Source
  • Mark Frye
    Mark Frye, MD

    Psychiatry

    •

    Mayo Clinic

    The potential of having a biological test to help accurately diagnose bipolar disorder would make a huge difference to medical practice,

    Source
  • Lena Smirnova
    Lena Smirnova, PhD

    Public Health

    •

    Johns Hopkins Bloomberg School of Public Health

    This is very exciting, because right now, there isn’t a blood marker for disorders affecting the brain.

    Source
  • George Papakostas
    George Papakostas, MD

    Psychiatry

    •

    Harvard Medical School; Massachusetts General Hospital

    Adding an objective biological test could improve diagnostic accuracy and may also help us track individual patients’ response to treatment.

    Source

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Newsletters

Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Your Privacy Choices
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.